Last Friday they announced the value of the reimbursement- all we are waiting on now is the charge code. One final hurdle and we should see a significant re-rate of the SP.
More importantly the company will be back on track to break even. It’s taken a while but once it’s there - game on.
- Forums
- NZX - By Stock
- PEB
- Ann: Cxbladder Commercial Evaluation by Johns Hopkins Medicine
Ann: Cxbladder Commercial Evaluation by Johns Hopkins Medicine, page-2
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PEB (NZSX) to my watchlist
(20min delay)
|
|||||
Last
15.8¢ |
Change
0.000(0.00%) |
Mkt cap ! n/a |
Open | High | Low | Value | Volume |
15.8¢ | 15.8¢ | 15.8¢ | $363 | 2.298K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
0 | 73847 | 15.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.5¢ | 31500 | 0 |
Last trade - 05.59am 07/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
PEB (NZSX) Chart |